"We will see if the loyalty to ACC goes both ways. We need something fast."
Were you hired in 2013?
This is Hospira.
The only thing fast here was the number of stock options sold in early 2010.
It's been a hoot reading these ACC comments on Voluven, Precedex, Dyloject.....
from both a management (keep em guessing) and an employee prespective.
Hospira should focus on injectables.....sell or burn the rest.
They got the rest of you buffaloed.
